Personal Info
- Country of residence: Palestine
Information
A
Palestinian woman obtains a patent for pancreatic cancer treatment in Spain
Palestinian
researcher Baraa Abu Asaker obtained a patent for a drug compound that can
definitively treat pancreatic cancer.
According
to what was published by the Palestinian media, the researcher Abu Asaker, who
resides in Spain and is enrolled as a PhD student at the University of
Barcelona, obtained a patent for the “p1.3 peptidomimetic” compound, which is
designed to bind to a protein responsible for the emergence of pancreatic
cancer, as the function of this compound is to inhibit the action of the
carcinogenic protein. .
Abu
Asaker indicated that the aforementioned treatment was reached after two
continuous years of her work in intensive research at the University of
Barcelona for the Faculty of Medicine, Department of “Biomedicine / hospital
Clinic”, to culminate in her research by signing the patent on February 18,
from the Spanish pharmaceutical company. Bosch i Gimpera”.
This
treatment has obtained results of up to 80 percent in killing cancer cells, in
addition to not affecting normal cells.
It is
noteworthy that the researcher Abu Asaker, a Palestinian resident of the Gaza
Strip, graduated from the Islamic University in 2016, and was appointed after
graduation as a lecturer at the university. In 2019 she obtained her master's
degree at the University of Barcelona and is now a demonstrator in her PhD
programme.
Palestinians
and Arabs circulated the news that the researcher Abu Asaker had obtained a
patent on a large scale through social media platforms.
source
Achievements and Awards
- Years in active
: From
To